| Name | MAX-40279 hemifumarate |
|---|
| Description | MAX-40279 hemifumarate is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 hemifumarate has the potential for the research of acute myelogenous leukemia (AML) (extracted from patent WO2021180032)[1]. |
|---|---|
| Related Catalog | |
| Target |
FLT3 and FGFR[1] |
| References |
[1]. Yuguang Wang, et al. Novel Therapeutic Methods. Patent WO2021180032A1. |
| Molecular Formula | C26H27FN6O5S |
|---|---|
| Molecular Weight | 554.59 |